11/06/2024
6:21 AM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/09/2024
3:18 PM | Aclaris Therapeutics (Subject)
MILLENNIUM MANAGEMENT LLC (Filed by)
| Form SC 13G/A | |
10/03/2024
3:15 PM | Aclaris Therapeutics (Issuer)
Walker Neal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
6:52 PM | Aclaris Therapeutics (Issuer)
Balthaser Kevin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
4:08 PM | Aclaris Therapeutics (Issuer)
Walker Neal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/13/2024
3:15 PM | Aclaris Therapeutics (Issuer)
Walker Neal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/07/2024
3:30 PM | Aclaris Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
|
08/07/2024
6:15 AM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/31/2024
3:10 PM | Aclaris Therapeutics (Issuer)
Leonard Braden Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/16/2024
3:30 PM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/08/2024
3:32 PM | Aclaris Therapeutics (Subject)
BlackRock Inc. (Filed by)
| Form SC 13G/A | |
07/05/2024
1:46 PM | Aclaris Therapeutics (Issuer)
Leonard Braden Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/01/2024
12:39 PM | Aclaris Therapeutics (Issuer)
Leonard Braden Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
5:04 PM | Aclaris Therapeutics (Issuer)
Leonard Braden Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
3:30 PM | Aclaris Therapeutics (Issuer)
SCHIFF ANDREW N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
3:30 PM | Aclaris Therapeutics (Issuer)
Mehra Anand (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
3:30 PM | Aclaris Therapeutics (Issuer)
GOWEN MAXINE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
3:30 PM | Aclaris Therapeutics (Issuer)
Humphries William D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
3:30 PM | Aclaris Therapeutics (Issuer)
MILANO VINCENT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
3:30 PM | Aclaris Therapeutics (Issuer)
Molineaux Christopher P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
3:30 PM | Aclaris Therapeutics (Issuer)
Powell Andrew Kenneth William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
3:30 PM | Aclaris Therapeutics (Issuer)
Reasons Bryan M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
3:30 PM | Aclaris Therapeutics (Issuer)
Walker Neal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
3:06 PM | Aclaris Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
04/25/2024
6:00 AM | Aclaris Therapeutics (Filer)
| Form DEF 14A | |
04/25/2024
6:01 AM | Aclaris Therapeutics (Filer)
| Form DEFA14A | |
04/25/2024
6:02 AM | Aclaris Therapeutics (Filer)
| Form ARS | |
04/03/2024
4:00 PM | Aclaris Therapeutics (Issuer)
Walker Neal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
4:08 PM | Aclaris Therapeutics (Issuer)
Walker Neal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2024
6:30 AM | Aclaris Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/27/2024
6:14 AM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
7:32 PM | Aclaris Therapeutics (Subject)
Venrock Healthcare Capital Partners II, L.P. (Filed by)
| Form SC 13G/A | |
02/14/2024
9:30 AM | Aclaris Therapeutics (Subject)
BIOTECHNOLOGY VALUE FUND L P (Filed by)
| Form SC 13G/A | |
02/13/2024
1:24 PM | Aclaris Therapeutics (Subject)
Foresite Capital Fund IV, L.P. (Filed by)
| Form SC 13G/A | |
02/08/2024
10:14 AM | Aclaris Therapeutics (Subject)
BML Investment Partners, L.P. (Filed by)
| Form SC 13G/A | |
02/08/2024
9:47 AM | Aclaris Therapeutics (Issuer)
Leonard Braden Michael (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/05/2024
6:29 PM | Aclaris Therapeutics (Issuer)
Loerop James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
6:31 PM | Aclaris Therapeutics (Issuer)
Monahan Joseph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
6:36 PM | Aclaris Therapeutics (Issuer)
Walker Neal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
6:27 PM | Aclaris Therapeutics (Issuer)
Balthaser Kevin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
3:31 PM | Aclaris Therapeutics (Filer)
| Form 8-K/A | |
There is a little known company that is changing warfare (Ad) With geo - political instability around the world investors are flocking to defense contract stocks.
There is a little known company that is changing warfare. With the backing of U.S. government contracts, this startup is reshaping the future of the U.S. military. Click here to gain instant access to one of the most exclusive pre-ipo opportunities in the market t |
01/19/2024
6:30 AM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/16/2024
4:24 PM | Aclaris Therapeutics (Subject)
BML Investment Partners, L.P. (Filed by)
| Form SC 13G | |
12/11/2023
3:25 PM | Aclaris Therapeutics (Subject)
MILLENNIUM MANAGEMENT LLC (Filed by)
| Form SC 13G | |
12/11/2023
8:36 AM | Aclaris Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
11/24/2023
12:49 PM | Aclaris Therapeutics (Subject)
TANG CAPITAL PARTNERS LP (Filed by)
| Form SC 13G | |
